Signaling by SCF-KIT
Masson K, Rönnstrand L. Oncogenic signaling from the hematopoietic growth factor receptors c-Kit and Flt3. Cell Signal. 2009 Dec;21(12):1717–26. doi: 10.1016/j.cellsig.2009.06.002. PMID: 19540337.; Edling CE, Hallberg B. c-Kit—A hematopoietic cell essential receptor tyrosine kinase. The International Journal of Biochemistry & Cell Biology. 2007;39(11):1995–8. doi: 10.1016/j.biocel.2006.12.005.; Reber L, Da Silva CA, Frossard N. Stem cell factor and its receptor c-Kit as targets for inflammatory diseases. Eur J Pharmacol. 2006 Mar 08;533(1-3):327–40. doi: 10.1016/j.ejphar.2005.12.067. PMID: 16483568.; Lennartsson J, Rönnstrand L. The stem cell factor receptor/c-Kit as a drug target in cancer. Curr Cancer Drug Targets. 2006 Feb;6(1):65–75. doi: 10.2174/156800906775471725. PMID: 16475976.; Rönnstrand L. Signal transduction via the stem cell factor receptor/c-Kit. Cellular and Molecular Life Sciences. 2004 Oct;61(19-20):2535–48. doi: 10.1007/s00018-004-4189-6.; Crosier P, Ricciardi S, Hall L, Vitas M, Clark S, Crosier K. Expression of isoforms of the human receptor tyrosine kinase c-kit in leukemic cell lines and acute myeloid leukemia. 1993 Aug 15;82(4):1151–8. doi: 10.1182/blood.v82.4.1151.bloodjournal8241151.; Rosnet O, Matteï MG, Marchetto S, Birnbaum D. Isolation and chromosomal localization of a novel FMS-like tyrosine kinase gene. Genomics. 1991 Feb;9(2):380–5. doi: 10.1016/0888-7543(91)90270-o. PMID: 2004790.